WordNet

pertaining to respiration; "respiratory assistance"
a breathing device for administering long-term artificial respiration (同)inhalator

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. フルオロキノロン類 fluoroquinolones
2. 成人における市中肺炎の治療に関する抗菌薬の研究 antibiotic studies for the treatment of community acquired pneumonia in adults
3. フルオロキノロン類、ドキシサイクリン、およびトリメトプリムスルファメトキサゾールに対する肺炎レンサ球菌の耐性 resistance of streptococcus pneumoniae to the fluoroquinolones doxycycline and trimethoprim sulfamethoxazole
4. 入院を要する成人における市中肺炎の治療 treatment of community acquired pneumonia in adults who require hospitalization
5. 重症筋無力症患者に対する麻酔 anesthesia for the patient with myasthenia gravis

Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study.

Barr HL1, Halliday N2, Barrett DA3, Williams P2, Forrester DL4, Peckham D5, Williams K5, Smyth AR6, Honeybourne D7, L Whitehouse J7, Nash EF7, Dewar J8, Clayton A8, Knox AJ4, Cámara M2, Fogarty AW9.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.J Cyst Fibros.2016 Oct 20. pii: S1569-1993(16)30617-8. doi: 10.1016/j.jcf.2016.10.005. [Epub ahead of print]
BACKGROUND: Pulmonary P. aeruginosa infection is associated with poor outcomes in cystic fibrosis (CF) and early diagnosis is challenging, particularly in those who are unable to expectorate sputum. Specific P. aeruginosa 2-alkyl-4-quinolones are detectable in the sputum, plasma and urine of adults
PMID 27773591

Inhibitory Effects of Multiple-Dose Treatment with Baicalein on the Pharmacokinetics of Ciprofloxacin in Rats.

Hwang YH1, Yang HJ1, Kim DG1, Ma JY2.
Phytotherapy research : PTR.Phytother Res.2016 Sep 26. doi: 10.1002/ptr.5728. [Epub ahead of print]
Ciprofloxacin is used as a treatment for urinary and respiratory tract infections in clinical practice. Baicalein, a major flavonoid present in Scutellaria baicalensis, is a well-known and potent antibacterial compound used in complementary and alternative medicine practices. The present study aimed
PMID 27671796

Cag Y1, Caskurlu H1, Fan Y2, Cao B3, Vahaboglu H1.
Annals of translational medicine.Ann Transl Med.2016 Sep;4(17):326.
By definition, the terms sepsis and septic shock refer to a potentially fatal infectious state in which the early administration of an effective antibiotic is the most significant determinant of the outcome. Because of the global spread of resistant bacteria, the efficacy of antibiotics has been sev
PMID 27713884

大石匠,深谷千絵,笠井俊輔,太田淳也,国分栄仁,齋藤淳,石原和幸,中川種昭
日本歯周病学会会誌 56(4), 406-413, 2015
本研究は，in vitro バイオフィルムに対するシタフロキサシン（STFX）の効果を検討することを目的とした。歯周病においてバイオフィルムは複数菌で構成され，抗菌薬に耐性を示すことが知られている。 STFX はニューキノロン系経口抗菌薬であり嫌気性口腔細菌を含む幅広い抗菌スペクトラムを示す。我々は微量流体デバイス BioFlux を採用した。BioFlux は嫌気条件下で自動的に培地を排出可能で …
NAID 130004842590

Efficacy and safety of garenoxacin tablets on clinically diagnosed atypical pneumonia: Postmarketing surveillance in Japan

Izumikawa Koichi,Watanabe Akira,Miyashita Naoyuki,Ishida Tadashi,Hosono Hiroaki,Kushimoto Satoru,Kohno Shigeru
Journal of Infection and Chemotherapy 20(9), 541-548, 2014-09
… We performed a postmarketing surveillance study to determine the efficacy and safety of the oral quinolone antibacterial agent garenoxacin (Geninax ® Tablets 200 mg) against atypical pneumonia. … we collected survey forms from 105 of these patients who were suspected of having atypical pneumonia based on the Japanese Respiratory Society Guidelines for the Management of Community-Acquired Pneumonia in Adults. …
NAID 120005477081

Fluoroquinolone Resistance Mechanism of Clinical Isolates and Selected Mutants of Pasteurella multocida from Bovine Respiratory Disease in China

, , [他], ,
Journal of Veterinary Medical Science 76(12), 1655-1657, 2014
… The minimum inhibitory concentrations (MICs), mutation prevention concentrations (MPCs) and contribution of quinolone resistance-determining region (QRDR) mutations to fluoroquinolone (ciprofloxacin, enrofloxacin and orbifloxacin) susceptibility in 23 Pasteurella multocida (Pm) isolates were investigated. …
NAID 130004780989